Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Krempski
Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity Against Gliomas With Increased Tumor Specificity
Cancer Research
Cancer Research
Oncology
Related publications
Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted Against the Urokinase Receptor
Cancer Research
Cancer Research
Oncology
Antitumor Efficacy of 34.5ENVE: A Transcriptionally Retargeted and “Vstat120”-Expressing Oncolytic Virus
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Expression of Immunomodulatory Neutrophil-Activating Protein of Helicobacter Pylori Enhances the Antitumor Activity of Oncolytic Measles Virus
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Potent Antitumor Effect of Tumor Microenvironment-Targeted Oncolytic Adenovirus Against Desmoplastic Pancreatic Cancer
International Journal of Cancer
Cancer Research
Oncology
High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus
Cancer Research
Cancer Research
Oncology
Specific Elimination of CD133+ Tumor Cells With Targeted Oncolytic Measles Virus
Cancer Research
Cancer Research
Oncology
Dual Promoter-Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models
Clinical Cancer Research
Cancer Research
Oncology
Oncolytic Herpes Virus Retargeted to HER-2
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Oncolytic Potency and Reduced Virus Tumor-Specificity in Oncolytic Virotherapy. A Mathematical Modelling Approach
PLoS ONE
Multidisciplinary
